|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
| 22.06 USD | +2.27% |
|
+5.30% | +20.22% |
| 07.07. | ACADIA PHARMACEUTICALS INC. : erhält Kaufen-Rating von RBC Capital Markets | ZM |
| 26.06. | Acadia Pharmaceuticals: RBC Sieht Aktienkurs Unterbewertet - Großes Potenzial für Nuplazid und Daybue | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränderung - 1 Monat | Veränderung - 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 J. | Veränd. 5 J. | Veränd. 10 J. | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +2.27% | +5.30% | -0.63% | +56.34% | +20.22% | +28.93% | +40.15% | -60.22% | -49.80% | 3.69 Mrd. | ||
| -1.05% | +1.36% | -2.12% | +8.21% | +5.34% | +10.67% | -0.81% | +4.83% | +311.67% | 50.45 Mrd. | ||
| -0.90% | +3.22% | -3.81% | +21.64% | +37.18% | +73.51% | +34.25% | +29.26% | - | 30.01 Mrd. | ||
| +1.42% | +5.74% | +11.49% | +20.22% | -0.94% | +4.18% | +11.14% | -34.87% | +223.79% | 28.73 Mrd. | ||
| +2.17% | +0.53% | +7.38% | +5.42% | -15.77% | -22.30% | -24.53% | +14.17% | +129.39% | 28.64 Mrd. | ||
| -0.07% | -0.72% | +2.99% | +29.36% | +22.86% | +26.87% | -22.19% | +13.02% | +106.76% | 12.7 Mrd. | ||
| +1.02% | +1.31% | +5.07% | +6.61% | -27.49% | -53.73% | -30.23% | -10.53% | +129.71% | 12.08 Mrd. | ||
| +0.44% | +1.33% | +2.40% | +23.14% | +28.20% | +28.51% | +88.54% | +28.85% | +810.68% | 10.69 Mrd. | ||
| +1.23% | -0.19% | +5.15% | +17.19% | +6.00% | +17.83% | -5.21% | +2.77% | +78.28% | 10.51 Mrd. | ||
| +2.04% | -2.25% | -14.10% | +47.93% | +76.54% | +70.29% | - | - | - | 10.32 Mrd. | ||
| +2.27% | +2.10% | +7.30% | +16.26% | -1.20% | -21.67% | +109.44% | +234.32% | - | 9.43 Mrd. | ||
| +3.46% | +2.39% | +5.86% | +10.45% | -24.46% | -24.50% | -41.17% | -20.10% | +120.33% | 8.53 Mrd. | ||
| +0.61% | +0.76% | +1.06% | +61.12% | +48.28% | +11.54% | +128.58% | +63.77% | +361.56% | 8.37 Mrd. | ||
| -4.80% | -27.95% | +2.41% | +2’128.88% | +12’642.31% | +18’143.39% | +1’556.50% | - | - | 8.19 Mrd. | ||
| +2.95% | +3.92% | +10.99% | +17.68% | -11.34% | -18.92% | -29.28% | -11.60% | +127.37% | 8.04 Mrd. | ||
| -0.05% | +1.66% | -8.29% | +14.35% | -11.98% | -9.33% | +64.46% | +26.27% | - | 7.17 Mrd. | ||
| -1.05% | -1.44% | +15.04% | +58.67% | +21.22% | -11.43% | +14.08% | -31.74% | -20.79% | 6.75 Mrd. | ||
| +0.52% | +7.58% | +11.09% | +30.10% | +5.97% | +19.83% | -51.73% | -44.56% | +119.24% | 6.66 Mrd. | ||
| -.--% | -.--% | - | - | - | - | - | - | - | 6.07 Mrd. | ||
| +0.40% | +2.45% | +2.41% | +12.71% | -2.33% | +34.22% | -64.31% | -44.19% | - | 5.8 Mrd. | ||
| Durchschnitt | +0.59% | -0.91% | +3.25% | +136.12% | +674.66% | +963.57% | +98.76% | +9.38% | +188.32% | 13.64 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | +0.37% | -0.81% | +2.69% | +84.31% | +396.69% | +568.19% | +58.92% | +10.39% | +223.73% |
- Börse
- Aktien
- 603035 Aktie
- Sektor ACADIA Pharmaceuticals Inc.
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben